Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02200224 · ClinicalTrials.gov registry record · NA

Clinical Utility of Rapid CT/NG Testing in the ED

A NA study, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
300
Enrollment target

NCT02200224: Completed NA study, sponsored by Johns Hopkins University.

NCT02200224 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 300 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02200224, a NA study, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
300 participants
Enrollment target

Study Summary

The purpose of this study is to: 1. determine the clinical impact of rapid Chlamydia Trachomatis (CT), Neisseria Gonorrhoeae (NG) testing on antibiotic over and under treatment for CT/NG in women evaluated in the Emergency Department (ED) for a Sexually Transmitted Infection (STI). 2. determine the clinical impact of rapid Trichomonas Vaginalis (TV) testing on antibiotic under and over treatment for TV in women evaluated in the ED for an STI 3. evaluate the feasibility of integrating rapid Chlamydia Trachomatis (CT), Neisseria Gonorrhoeae (NG) and TV testing in the Emergency Department setting. To evaluate the impact or rapid CT/NG/TV testing an patient comprehension of Sexually Transmitted Infection diagnosis.

Interventions

  • OTHER Rapid Testing

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2015-04
Est. Completion 2016-05
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT02200224

The ClinicalTrials.gov registry entry for NCT02200224 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Rapid Testing is the first listed.

NCT02200224 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02200224 about?

NCT02200224 is a clinical study titled "Clinical Utility of Rapid CT/NG Testing in the ED". The purpose of this study is to: 1. determine the clinical impact of rapid Chlamydia Trachomatis (CT), Neisseria Gonorrhoeae (NG) testing on antibiotic over and under treatment for CT/NG in women evaluated in the Emergency Department (ED) for a Sexually Transmitted Infection (STI). 2. determine the...

What is the current status of trial NCT02200224?

This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2015-04. Estimated completion is 2016-05.

What interventions are being tested in trial NCT02200224?

The interventions under investigation include: Rapid Testing (OTHER).

Who is sponsoring clinical trial NCT02200224?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.